article thumbnail

The Economics of Investigational Device Exemption (IDE) Studies: What You Need to Know About Medicare Coverage

The Premier Consulting Blog

This article reviews the regulations governing charging or obtaining insurance coverage for an investigational device. 2] Code of Federal Regulations. 3] Code of Federal Regulations. Resources [1] US Food and Drug Administration. Investigational Device Exemption. Available at [link]. [2] Available at [link]. [3] Application.

article thumbnail

The Gig Economy, Nightwork, and Stimulant Use

Common Sense for Drug Policy Blog

Melatonin, the hormone involved in the regulation of our biological clock, is released when we are exposed to daylight. "But working at night is not necessarily good for us.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article Periodic Thank You EPA publishes draft Meaningful Involvement Policy

Agency IQ

EPA publishes draft Meaningful Involvement Policy The Environmental Protection Agency has released a draft of its Meaningful Involvement Policy, an update of a 2003 policy, which seeks to improve the interactions of the agency with stakeholders about agency actions. To contact the author of this analysis, please email Walker Livingston.

article thumbnail

Drugs Companies Clap Back at Congress…Then Get Sued

FDA Law Blog: Biosimilars

In fact, federal law and regulation appear to require AbbVie to list these patents.” Kaleo also delisted, but not without noting that “the decision to list each of these patents was proper, consistent, and required by the applicable statutes, regulations, and FDA’s guidance available at the time of listing.”

Drugs 57
article thumbnail

Gamma delta T cells: a rising star in cancer therapy

Drug Target Review

from 2003 to 2006, covering the biotechnology and life-science tools sectors. Regulation of cutaneous malignancy by gammadelta T cells. J Exp Med 198(5):747-755 (2003). Previously, Mr Ho served as a Senior Equity Research Analyst at Bank of America from 2006 to 2009 and an Equity Research Analyst at Piper Jaffray & Co.

Therapies 105
article thumbnail

Biophytis Announces Plan to Publicly File Later Today Registration Statement for Proposed Initial Public Offering in the United States

The Pharma Data

This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to any securities of Biophytis in any country.

article thumbnail

New drug boosts foetal haemoglobin to fight sickle cell disease

Drug Target Review

Results of the Multicenter Study of Hydroxyurea in Sickle Cell Anaemia published in the Journal of the American Medical Association in 2003, indicated that the use of hydroxyurea, the only drug approved at the time, reduced mortality as it reduced pain crises and increased foetal haemoglobin.

Disease 80